Camlin Fine Sciences Reports ₹4.57 Billion Revenue, Posts Net Loss of ₹362.3 Million in Q3 FY26

Camlin Fine Sciences Ltd, a leading player in the specialty chemicals and food ingredients sector, has announced its December quarter (Q3 FY26) financial results. The company recorded consolidated revenue from operations of ₹4.57 billion, but reported a consolidated net loss of ₹362.3 million.

The performance highlights ongoing challenges in raw material price fluctuations and global demand pressures, which impacted profitability despite steady revenue growth. Camlin Fine Sciences continues to focus on innovation, operational efficiency, and expansion into international markets to strengthen its long-term positioning.

Key Highlights

• Revenue Performance: Consolidated revenue from operations stood at ₹4.57 billion in Q3 FY26.
• Profitability: Consolidated net loss of ₹362.3 million reported.
• Operational Challenges: Margin pressures due to raw material cost volatility and global demand slowdown.
• Business Strength: Continued focus on specialty chemicals and food ingredients portfolio.
• Future Outlook: Strategic emphasis on efficiency, innovation, and global expansion to drive recovery.

Camlin Fine Sciences’ results underline the need for resilience in a competitive global chemicals market. With demand for specialty ingredients expected to rise, the company is positioning itself for sustainable growth despite near-term profitability challenges.

Sources: BSE Filings, Moneycontrol, Mint